OKYO Pharma Ltd ADR (US: OKYO) — Healthcare · Share Price, Chart & Market Data
About: OKYO Pharma Limited, a clinical-stage biopharmaceutical company, develops therapeutics for patients suffering from inflammatory eye diseases and ocular pain in the United Kingdom. Its lead clinical product candidate is urcosimod, which is in Phase II clinical trials for the treatment of dry eye disease; in Phase II clinical trial to treat neuropathic corneal pain; and is in preclinical trial to treat allergic conjunctivitis and uveitis. The company is also developing OK-201 for the treatment acute and chronic ocular pain. OKYO Pharma Limited was incorporated in 2007 and is headquartered in London, the United Kingdom.
Sector: Healthcare
Industry: Biotechnology
Latest price: $1.61 (+1.26%)
OKYOOKYO Pharma Ltd ADR
Loading watchlist status…
Trade OKYO now
OKYO Pharma Ltd ADR share price
OKYO price activity
Last Price
Change (24hr)
USD (%)
Volume
Volume (4w avg)
Previous Close
N/A
Last Trade
Delayed
27 Apr, 9:24 am GMT+0
OKYO price performance
3.871%
5D
5.229%
1M
-27.803%
YTD
3.871%
1Y
OKYO price fundamentals
N/A
Shares Issued
N/A
Dividends Per Share (DPS)
N/A
Earnings Per Share (EPS)
N/A
P/E Ratio
Price market cap
Market cap
N/A
US rank
N/A
Sector Rank
N/A
Delayed
27 Apr, 9:24 am GMT+0
OKYO details
OKYO Market Signals